TY - JOUR
T1 - Dynamic 3D analysis of myocardial sympathetic innervation
T2 - An experimental study using 123I-MIBG and a CZT camera
AU - Giorgetti, Assuero
AU - Burchielli, Silvia
AU - Positano, Vincenzo
AU - Kovalski, Gil
AU - Quaranta, Angela
AU - Genovesi, Dario
AU - Tredici, Manuel
AU - Duce, Valerio
AU - Landini, Luigi
AU - Trivella, Maria Giovanna
AU - Marzullo, Paolo
PY - 2015/3/1
Y1 - 2015/3/1
N2 - Data on the in vivo myocardial kinetics of 123I-metaiodobenzylguanidine (123I-MIBG) are scarce and have always been obtained using planar acquisitions. To clarify the normal kinetics of 123I-MIBG in vivo over time, we designed an experimental protocol using a 3-dimensional (3D) dynamic approach with a cadmium zinc telluride (CZT) camera. Methods: We studied 6 anesthetized pigs (mean body weight, 37 ± 4 kg). Left ventricular myocardial perfusion and sympathetic innervation were assessed using 99mTc-tetrofosmin (26 ± 6 MBq), 123I-MIBG (54 ± 14 MBq), and a CZT camera. A normal perfusion/function match on gated SPECT was the inclusion criterion. A dynamic acquisition in list mode started simultaneously with the bolus injection of 123I-MIBG, and data were collected every 5 min for the first 20 min and then at acquisition steps of 30, 60, 90, and 120 min. Each step was reconstructed using dedicate software and reframed (60 s/frame). On the reconstructed transaxial slice that best showed the left ventricular cavity, regions of interest were drawn to obtain myocardial and blood pool activities. Myocardial time-activity curves were generated by interpolating data between contiguous acquisition steps, corrected for radiotracer decay and injected dose, and fitted to a bicompartmental model. Time to myocardial maximum signal intensity (MSI), MSI value, radiotracer retention index (RI, myocardial activity/blood pool integral), and washout rate were calculated. The mediastinal signal was measured and fitted to a linear model. Results: The myocardial MSI of 123I-MIBG was reached within 5.57 ± 4.23 min (range, 2-12 min). The mean MSI was 0.426% ± 0.092%. Myocardial RI decreased over time and reached point zero at 176 ± 31 min (range, 140-229 min). The ratio between myocardial and mediastinal signal at 15 and 125 min and extrapolated at 176 and 4 h was 5.45% ± 0.61%, 4.33% ± 1.23% (not statistically significant vs. 15 min), 3.95% ± 1.46% (P <0.03 vs. 125 min), and 3.63% ± 1.64% (P <0.03 vs. 176 min), respectively. Mean global washout rate at 125 min was 15% ± 14% (range, 0%-34%), and extrapolated data at 176 min and 4 h were 18% ± 18% (range, 0.49%-45%) and 25% ± 23% (range, 1.7%-56.2%; not statistically significant vs. 176 min), respectively. Conclusion: 3D dynamic analysis of 123I-MIBG suggests that myocardial peak uptake is reached more quickly than previously described. Myocardial RI decreases over time and, on average, is null about 3 h after injection. The combination of an early peak and variations in delayed myocardial uptake could result in a wide physiologic range of washout rates. Mediastinal activity appears to be constant over time and significantly lower than previously described in planar studies, resulting in a higher heart-to-mediastinum ratio.
AB - Data on the in vivo myocardial kinetics of 123I-metaiodobenzylguanidine (123I-MIBG) are scarce and have always been obtained using planar acquisitions. To clarify the normal kinetics of 123I-MIBG in vivo over time, we designed an experimental protocol using a 3-dimensional (3D) dynamic approach with a cadmium zinc telluride (CZT) camera. Methods: We studied 6 anesthetized pigs (mean body weight, 37 ± 4 kg). Left ventricular myocardial perfusion and sympathetic innervation were assessed using 99mTc-tetrofosmin (26 ± 6 MBq), 123I-MIBG (54 ± 14 MBq), and a CZT camera. A normal perfusion/function match on gated SPECT was the inclusion criterion. A dynamic acquisition in list mode started simultaneously with the bolus injection of 123I-MIBG, and data were collected every 5 min for the first 20 min and then at acquisition steps of 30, 60, 90, and 120 min. Each step was reconstructed using dedicate software and reframed (60 s/frame). On the reconstructed transaxial slice that best showed the left ventricular cavity, regions of interest were drawn to obtain myocardial and blood pool activities. Myocardial time-activity curves were generated by interpolating data between contiguous acquisition steps, corrected for radiotracer decay and injected dose, and fitted to a bicompartmental model. Time to myocardial maximum signal intensity (MSI), MSI value, radiotracer retention index (RI, myocardial activity/blood pool integral), and washout rate were calculated. The mediastinal signal was measured and fitted to a linear model. Results: The myocardial MSI of 123I-MIBG was reached within 5.57 ± 4.23 min (range, 2-12 min). The mean MSI was 0.426% ± 0.092%. Myocardial RI decreased over time and reached point zero at 176 ± 31 min (range, 140-229 min). The ratio between myocardial and mediastinal signal at 15 and 125 min and extrapolated at 176 and 4 h was 5.45% ± 0.61%, 4.33% ± 1.23% (not statistically significant vs. 15 min), 3.95% ± 1.46% (P <0.03 vs. 125 min), and 3.63% ± 1.64% (P <0.03 vs. 176 min), respectively. Mean global washout rate at 125 min was 15% ± 14% (range, 0%-34%), and extrapolated data at 176 min and 4 h were 18% ± 18% (range, 0.49%-45%) and 25% ± 23% (range, 1.7%-56.2%; not statistically significant vs. 176 min), respectively. Conclusion: 3D dynamic analysis of 123I-MIBG suggests that myocardial peak uptake is reached more quickly than previously described. Myocardial RI decreases over time and, on average, is null about 3 h after injection. The combination of an early peak and variations in delayed myocardial uptake could result in a wide physiologic range of washout rates. Mediastinal activity appears to be constant over time and significantly lower than previously described in planar studies, resulting in a higher heart-to-mediastinum ratio.
KW - <sup>23</sup>i-MIBG
KW - Cardiac sympathetic innervation
KW - CZT
KW - Ultrafast cardiac camera
UR - http://www.scopus.com/inward/record.url?scp=84928153350&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84928153350&partnerID=8YFLogxK
U2 - 10.2967/jnumed.114.143669
DO - 10.2967/jnumed.114.143669
M3 - Article
C2 - 25635134
AN - SCOPUS:84928153350
VL - 56
SP - 464
EP - 469
JO - Journal of Nuclear Medicine
JF - Journal of Nuclear Medicine
SN - 0161-5505
IS - 3
ER -